News

Oxford Endovascular Ltd raises $10m to develop its origami engineered medical device to prevent brain haemorrhage

Posted on

Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spinout from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in a series A funding round. The funding […]

News

Oxford Endovascular wins Innovate UK Smart Grant

Posted on

Press Release: Oxford, UK, 14th November 2020.   Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients suffering from brain aneurysms has been awarded non-dilutive grant funding of £350,000 match funded by the company with £150,000 via the prestigious Smart Grant Program run by Innovate UK, the UK’s innovation agency* […]

News

Oxford Endovascular awarded non-dilutive grant funding of up to 2.96 Million Euros to support R&D activities and clinicals

Posted on

  ‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’   This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 859001   Mike Karim, CEO, commented:   ‘We are delighted to have won this prestigious grant […]

News

Oxford Endovascular presents its next investment opportunity as it seeks $8M at the Med Tech Showcase, San Francisco, 9 Jan, 2019

Posted on

Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) for the minimally invasive treatment of intracranial aneurysms – a market around $1 Billion, 8% CAGR. The device has been designed by world leading Professors of Medicine & Engineering. OxiFlow, is inserted via […]

News

Oxford Endovascular presents on Intelligent Crowd TV

Posted on

On Monday, November 12th at 1600, Oxford Endovascular appeared live on ‘The Series A Hour with Match Capital’. This second series of the fortnightly live streaming TV show from Intelligent Crowd TV is aimed at the professional investor community in the UK, Europe and Asia and provides a new and efficient way to see the […]

News

May 2018, Oxford Endovascular raises £2.5M

Posted on

The company successfully raises £2.5M to continue its development work and progression through its animal studies over 2018/2019 in advance of making applications for its first in human and CE mark studies. The fundraise came from existing investors following on as well as Parkwalk, Oxford Investment Consultants, Perivoli and some private individuals investing.   Visit: https://www.eithealth.eu/-/eit-health-spain-picks-7-medtech-start-ups-to-compete-at-summit

News

EIT Health Spain picks Oxford Endovascular to compete in the European Health Catapult finals

Posted on

EIT Health Spain has announced the winning start-ups who will compete in the medical technology category in the European Health Catapult Contest. The start-ups were chosen in a pitching contest. These seven finalists will join start-ups competing in the biotech and digihealth categories in a competition to determine the “best-of-the-best” during the EIT Health Summit […]

News

Oxford Endovascular wins BioTrinity ‘Perfect Pitch’ competition 2017

Posted on

OBN, the membership organisation that supports innovative life sciences companies,  today announces that Mike Karim, CEO of Oxford Endovascular is the winner of Perfect Pitch, the fast-paced, interactive and lively pitching session which was a highlight of the BioTrinity 2017 conference programme. Perfect Pitch involved ten emerging R&D companies pitch in front of a panel of seasoned […]

News

What is Oxford Endovascular

Posted on

Oxford Endovascular Limited is a spin out from The University of Oxford. The Company is developing metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms. OE has raised £2m from investment company Oxford Sciences Innovation PLC, the University of Oxford Innovation Fund and private investors […]

Archives